The U.S. Food and Drug Administration (FDA) recently held a Patient Engagement Advisory Committee meeting focused on clinical trial informed ...
Breaking News] Gyeonggi Provincial Office of Education's Education Administration Information System Nice Some Obstacles â–¶ ...
EyePoint Pharmaceuticals' lead product, EYP-1901, shows promising phase 2 results for wet AMD and DME. Read more about EYPT ...
Prosecutors demanded a nine-year prison term in the appeal trial of Kim, the second son of Hancom Group Chairman Kim ...
Suvoda, a global clinical trial technology company specializing in complex studies in therapeutic areas like oncology, ...
Q3 2024 Earnings Call Transcript November 6, 2024 UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-0.55, ...
Two first-line cutaneous melanoma patients - one patient who was dose escalated from 70 mg to 210 mg and finally to 350 mg experienced a confirmed partial response (PR) at the higher dose; one patient ...
Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ETCompany ParticipantsLauren Marek - LifeSci AdvisorsLaura Niklason ...
2d
On track to report interim data in six-month evaluable patients in ADVANCED-2 trial of TARA-002 in NMIBC in 4Q 2024Expect to report interim ...
The Trump administration is expected to liberalise research into psychedelic-assisted therapies – and Emyria investors have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback